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Abstract 
 
Introduction: Malaria pre-elimination is reached in Zanzibar. Travel has earlier been 
identified as a risk factor for malaria in Zanzibar and import of malaria from Tanzania 
mainland has been proposed to fuel the residual transmission in Zanzibar.  
Objectives: To assess travel to mainland Tanzania as a risk factor and to describe 
characteristics of malaria patients in Zanzibar during 2016. 
Methods: This was a retrospective, descriptive and case-control study using quantitative data 
from a malaria surveillance system in Zanzibar. Malaria cases were clinical and confirmed by 
malaria rapid diagnostic test (mRDT) or microscopy. Questionnaire answers provided data for 
known risk factors for malaria such as recent travel history (within 30 days), not having slept 
under long lasting insecticide treated net (LLIN) (previous night) or not having done 
insecticide residual spraying (IRS) recently (within 8 months). 
Results: 48% of cases at health facilities had recent travel history outside Zanzibar. Recent 
travel was found to be a strong risk factor for malaria, unadjusted OR’s for different periods 
ranging 222-486 (CI 124-710, p<0.001). Tanzania mainland was reported as travel destination 
by 94% of all travel cases. LLIN was used by 64% and IRS done recently by 31% of all 
malaria cases, coverage varying by district. 
Conclusions and implications: A high proportion of malaria cases reporting recent travel 
suggests a large proportion of all malaria in Zanzibar is imported. Maintained uptake of 
interventions such as LLIN and IRS and continued surveillance and case follow-up are factors 
that affects the risk for onward transmission of imported malaria. Limiting imported malaria 
with suitable strategies could potentially help to accelerate further reduction and eliminate 
malaria in Zanzibar. 
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List of abbreviations 
   
ACT  Artemisinin Combination Therapy 
DALY Daily Adjusted Life Years 
DDT  Dichlorodiphenyltrichloroethane 
DMSO  District Malaria Surveillance Officer 
Pf Plasmodium falciparum 
GMEP  Global Malaria Eradication Program 
HF Health facility 
IRS  Indoor residual Spray 
LLIN Long Lasting Insecticide Nets 
MCN  Malaria Case Notification   
MDA  Mass Drug Administration  
MEEDS  Malaria Early Epidemic Detection System 
mRDT  Malaria Rapid Diagnostic Test 
MSAT  Mass Screen and Treat 
PCR  Polymerase Chain Reaction 
RACD  Reactive Case Detection 
RBM  Roll Back Malaria Initiative 
Rc  Reproduction rate with control measures 
Rο  Basic Reproduction rate with no control measures  
VC Vector control 
WHO  World Health Organization 
ZAMEP  Zanzibar Malaria Elimination Programme 
ZMCP  Zanzibar Malaria Control Programme 
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Introduction 
Global perspective on malaria 
In the year of 2015 roughly half of the global population was at risk of malaria, in total 214 
million malaria cases and 438´000 deaths. 70% of deaths occurring among children and 91% 
of all deaths in sub-Saharan Africa. (1) 
Although half of the global population is at risk, malaria is above all an affliction of the poor 
and the children of the world. Advances in standard of living and economic growth is haltered 
in development countries. 
Investing money in fighting malaria is next to childhood immunization considered to be the 
most cost-effective investment in public health, providing socioeconomic, developmental and 
equity benefits in addition to the more obvious health benefits. The cost of averting a malaria 
case is $5-8. It has been suggested that if the global malaria burden would be reduced by 50%, 
the estimated return of every US$1 invested would be US$36, or for sub-Saharan Africa, $60 
in return of interest. If the set goals for 2030 by the World Health Organization (WHO) will 
be successful, the benefits are colossal in multiple aspects and perspectives and the direct 
economic outcome is estimated to an economic output of US$4 trillion. The cost-effectiveness 
of malaria control is more well-known than for malaria elimination. Efforts of malaria 
elimination will likely impose a greater initial investment, but will over time catch up in 
effectiveness when shifting toward preventing resurgence. It’s estimated that the operating 
costs of sustaining elimination is only 65-75% that of a control programme. (2)  
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Malaria parasite 
Malaria is a vector born infectious disease of unicellular protozoan parasites of genus 
Plasmodium. The parasites are transmitted from human to human by female Anopheles 
mosquitos. There are five different malaria parasites causing malarial sickness in humans 
when entering our bloodstream, plasmodium (P.) vivax, P. ovale, P. knowlesi, P. malariae and 
P. falciparum. (3) P. falciparum is by great length the deadliest of the malaria species, 
causing 99% of all deaths in malaria in 2015.(1) 
Transmission intensity is determined by several factors, including the vector capability and 
the human recipients’ susceptibility. A strong vector breeds well, prefer to bite humans, occur 
in large numbers, is robust to changes and live long. Transmission intensity is largely 
determined by the strength of the vector and its numbers. In high transmission setting people 
are bitten by infectious mosquitos more often than in low transmission settings, the 
entomological inoculation rate (EIR) varies greatly in different regions. In sub-Saharan 
Africa, P. falciparum is the dominant parasite species and in several areas there are high EIR 
contributing to high transmission and endemicity. “Stable transmission” is common with 
year-around infection due to high EIR, putting children at high risk but most adults are 
immunized and asymptomatic. In different regions with pronounced seasonal transmission 
there is so-called “unstable transmission”, less frequent inoculation results in poor 
immunization and malaria can afflict all ages. Unstable, low transmission or seasonal 
transmission also results in a situation with much higher vulnerability for endemics, e.g. 
triggered by environmental changes, war or neglected malaria control. (4)  
The malaria life cycle 
Malaria parasites have stages in both human and mosquito necessary for replication. The 
cycle differs somewhat for different plasmodium species but have major similarities. The 
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knowledge of the life cycles gives insight to how to approach pharmaceutical therapies and 
different stages coincide with typical clinical features and symptoms of the disease. 
The vector mosquito infects the human host with sporozoites from the saliva while feeding. 
Sporozoites invade hepatocytes and multiply, creating daughter merozoites in 5.5-8 days. The 
liver schizonts bursts, releasing merozoites that will infect erythrocytes in the asexual blood 
cycle, lasting about 48 hours.  In erythrocytes, the parasite affects the cells in many ways and 
consumes cell contents while forming trophocytes, maturing into erythrocyte schizonts which 
will eventually burst and release merozoites. The asexual cycle will multiply the parasite 
number and after approximately 12-14 days the incubation period has passed, presenting the 
first clinical symptoms. This also usually marks the point when an infection could usually be 
detected by malaria rapid diagnostic testing (mRDT) or microscopy.  P. vivax and P. ovale 
can form hypnozoites, causing the incubation period to range from 2 weeks to more than a 
year. In the blood-stage of humans there is mainly multiplication of parasite by mitosis, but 
some parasites will develop into the sexual form of gametocytes, that can be transferred to 
feeding mosquitos and peak in numbers day 7-10. Meiosis of the parasites only happens in the 
mosquito and together with other stages in the mosquito completes the cycle.(4)  
 
Malaria disease 
Clinical characteristics and symptoms 
The initial symptoms are usually nonspecific, including malaise, headache, fever, myalgia, 
abdominal pain and nausea.(4) 
The characteristic clinical features and symptoms of recurring fever and chills that some 
might develop are linked and coincide with the rupture of erythrocyte schizonts. The 
paroxysm of illness and symptom-free periods vary in periodicity in different species, P. vivax 
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and P. ovale approximately every 48 h and P. malariae every 72 h, P. falciparum might have 
48 h cyclicity but is generally not showing this fever pattern but a more irregular. Remnants 
of parasitized erythrocytes and high levels of cytokines can in severe P. falciparum infections 
cause grave complications, causing obstruction of capillaries and post-capillary venules that 
will lead to hypoxia in affected organs and the release of toxic cellular products(5) In 
uncomplicated cases normal findings are an enlarged palpable spleen, mild anaemia, fever, 
jaundice (adults) and enlarged liver (children). In areas of stable high transmission chronic 
anaemia and splenomegaly can be found among children. Cerebral malaria is a potential 
symptom of P. falciparum in all ages, associated with general seizures and eventually 
followed by coma or death. Other severe outcomes vary by age but include acute kidney 
injury, acute pulmonary oedema, acidosis severe anaemia and hypoglycaemia. The relation 
between parasite density, symptoms and prognosis vary with status of immunization and 
availability of prompt effective treatment. (4) 
Diagnosis and treatment 
The WHO recommendation for handling suspected malaria is to confirm with parasitological 
test before treatment. In high endemic areas it’s recommended to test all with history of fever 
or presenting with fever. In areas of very low incidence it’s recommended to test only those 
with fever with no other obvious cause or if recent exposure to malaria (“e.g recent travel to a 
malaria-endemic area without protective measures”). (6)  
Swift handling of diagnosis and treatment brings down mortality, risk of severe outcomes and 
reduces further transmission by reducing total length of time patients carry malaria parasites 
in their blood. Testing with mRDT or microscopy prior to treatment is recommended to 
improve management of febrile disease and to aim for use of antimalarial medicines only 
when necessary. Artemisinin combination treatment (ACT) is the recommended treatment for 
uncomplicated P. falciparum malaria and has been showed to reduce mortality for children 
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aged 1-23 months by 99%, aged 34-59 months by 97%.(1) The ACT consists of a rapid acting 
artemisinin derivate coupled with a longer-lasting partner drug. Some considerations affects 
the choice of drugs combined, doses and days of treatment.(6) 
History of malaria 
Malaria is one of the diseases that have had greatest impact on humans, causing serious 
impact on our genome, tremendous amounts of mortality and morbidity. 
The first known note of malaria is from China 5,000 years ago, and the first of P. falciparum 
from India 3000 years ago. Malaria seems to have been known and causing epidemics in 
several of the great ancient civilizations, described by Egyptian texts dated over 3500 years 
old, Mesopotamian civilization and in ancient Greece. Alexander the Great died in 323 BC, 
supposedly from malaria, likely P. falciparum considering his young age and presumed good 
health otherwise.(3) 
The estimates of total deaths in malaria in the 20th century is about 150-300 million, or 2-5% 
of all causes of deaths. In the early 20th century malaria contributed as cause of death in up to 
10%. Although malaria used to be more widely spread than in modern times the magnitude of 
malarias toll varied greatly in different areas. In the early 20th century Europe and North 
America had relatively low prevalence of malaria compared to other regions and especially 
the regions worst affected. Large parts of Asia had a huge malaria problem from early to mid-
20th century, cause of about 10% of all death. In India malaria struck perhaps hardest, and for 
a period causing in large parts of the country about 50% of deaths, some regions annual rates 
of 150 per 10´000 or locally even higher to a point when it was no longer habitable. (3)  
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(3) 
Picture 1. Malaria mortality rate in the 20th century. 
Spanish colonizers were introduced to the antimalarial effects of Cinchona bark, quinine in 
the 17th century by natives in south America. Early European colonizers and traders travelling 
to the tropics had often as high as 50% death rate per year, mostly contributable to malaria but 
dysentery and yellow fever also major causes. When Europeans in west Africa in mid-19th 
century learned to use Cinchona bark to treat malaria the overall mortality rates dropped to 
less than a quarter. (3) 
Chloroquine, has contributed to malaria control and was widely used during the Global 
Malaria Elimination Program (GMEP) era but has since then, among other newer drugs fallen 
to resistance. (7) Following the abandonment of GMEP and reports of chloroquine- and DDT 
resistance in the 1970s the following two decades a marked increase in malaria incidence 
worldwide took place. (8)  
The prestigious Nobel prize has been awarded in total 4 times for important discoveries 
regarding malaria. (9) The latest was to professor Tu Youyou for her contributions in the 
discoveries of using artemisinin as an antimalarial drug. Artemisinin, has been used as 
treatment for fever and malaria in traditional Chinese medicine with notes dating back at least 
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1700 years. Professor Youyou was a project leader of the Chinese project 523, at first a secret 
research project initiated during rule of Mao Zedong, set out to find new treatment 
alternatives for malaria and as a response to a request from the Vietnamese government for 
help with malaria. (10) 
 
Even if GMEP failed its goal of global eradication it brought a lot good. Over the whole 
coarse of GMEP campaigns 15 countries and one territory successfully achieved elimination 
and other countries reduced malaria burden. In sub-Saharan Africa no substantial reduce was 
achieved and several areas had great resurges. (8) However, even in sub-Saharan Africa some 
long lasting benefits remains, despite the collapse of GMEP, import and spread of chloroquine 
resistant P. falciparum and resurgence of malaria the overall morbidity and mortality was 
somewhat reduced. Another valuable remnant is the infrastructure of field clinics for 
diagnosis and treatment, in some rural areas still the backbone of health care. (3)  
The failure of GMEP has been partially blamed on importation of malaria by reintroduction of 
transmission and the spread of chloroquine resistance, learning from history that imported 
malaria infections likely needs to be addressed to obtain malaria elimination. (11) 
Madagascar is an example of how quickly malaria can resurge. Madagascar managed between 
late 1960s to early 1980s to almost completely supress malaria transmission. The combination 
of an environment that naturally supports malaria transmission, almost all natural immunity 
against malaria lost and control efforts not sustained resulted 1986 in a reintroduction of 
malaria in Madagascar. For a few years an epidemic raged, affecting all age groups and likely 
claimed several tens of thousands of lives.(3) 
Malaria remains a great disease of poverty and its toll of today is still at an unacceptable level. 
The wealthy countries and regions of today might not have been able to acquire the high level 
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of prosperity without first eliminating malaria. There are still some of the poorest regions in 
the world totally overwhelmed by the effects of malaria.(3) 
 
Moderns efforts 
After the collapse and discontinuation of GMEP by WHO in 1969 some regions had further 
achievements in reducing malaria, while it resurged in others. 
The Roll Back Malaria (RBM) partnership, founded in 1998 has been central in the modern 
efforts of malaria control and elimination and in the aspiration to achieve the Millennium 
Development Goals (MDG). Since the world malaria community once again started up a 
massive, joint approach to fight malaria there has been an immense advancement in reducing 
the malaria burden and achieving malaria elimination.  The RBM partnership used their 
Global Malaria Action Plan (GMAP) 2008-2015 and for 2016-2030 have developed the 
document Action and Investment to defeat Malaria 2016-2030 (AIM). WHO has defined the 
Global Technical Strategy for Malaria (GTSM), describing the goals and targets for 2030 that 
AIM describes how to achieve. (2)  
Modern malaria efforts are coordinated from major players of the world malaria community 
such as WHO and RBM Partnership and their global policy documents. The community has 
endorsed a three-part strategy “for shrinking the malaria map”. The strategy includes 1) 
Aggressive control in the malaria heartland, 2) Progressive elimination from endemic 
margins, 3) Continued research and development to bring forward new tools. (12) 
Estimates of progress between 2000 and 2015 shows substantial reduction of malaria 
incidence by 41% and mortality by 62%, endemic countries and regions 91 compared to 108. 
(1) Also between 2000 to 2015 663 million clinical malaria cases are estimated to have been 
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averted by interventions, thereof ITN the largest contributor (68% of cases averted).(13) 
Between 2001-2015 more than 6.8 million deaths averted, primarily in children <5 years old. 
(14) 
WHO definitions of phases in malaria control and elimination 
WHO has defined phases of antimalarial activity and recommended agendas for malaria 
programs.  
1) Control – reduce and sustain disease burden to a low level. 
2) Pre-elimination – <5 cases / 1000 at risk per year, 1st reorientation of malaria program. 
3) Elimination – no local transmission or locally acquired cases, 2nd reorientation of malaria 
program. 
4) Prevention of reintroduction – if >3 years with no reported local transmission WHO can 
issue a certification of successful elimination. 
A control program aims to reduce disease burden by high uptake of preventive measures and 
access to health care, differing from the more technical demanding approach of an elimination 
program. Key-points in a malaria elimination program is to detect all malaria cases, prevent 
onward transmission, manage local foci and manage importation of malaria. (7) 
Continued efforts to prevent resurgence are needed until malaria incidence is reduced to zero 
worldwide, i.e. malaria eradication achieved.(8) 
 
Outlook for the future 
WHO goals of GTSM defines targets for malaria globally 2030 as compared to 2015 as 1) 
Reduced malaria mortality rates by at least 90%, 2) Reduced malaria case incidence by at 
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least 90%, 3) Eliminate malaria from 35 countries, 4) Prevent re-establishment of malaria in 
all countries that are malaria-free.(15) 
Bold statements are once again being made regarding malaria eradication, one is that we now 
have the opportunity to achieve a malaria free world within a generation. Serious discussions 
are up about what it would take to eradicate malaria and it has been proposed to set 2040 as 
the goal. They highlight the need of increased funding and greater investments but stress that 
from a not too far off point the peak in costs will be reached, thereafter the costs is expected 
to decline as regions achieve malaria elimination. The outcome could result in 11 million lives 
saved and economic benefits of $4 trillion. (16)  
The world malaria report of 2017 by WHO acknowledge substantial progress in fighting 
malaria globally but also identifies remaining challenges. The global malaria incidence has 
been reduced by 21% and mortality by 29% since 2010. The GTS goal to reduce global 
incidence and mortality in malaria by 40% until 2020 does not seem attainable, especially in 
the African region progress has been slow. The trends suggest an increased malaria burden 
between 2014 and 2016, circa 5 million more cases in 2016 than 2015 but number of deaths 
stable. Factors that might have contributed to the reversed trend were suggested to be 
inadequate funding, conflicts, climate patterns and inefficient implementation of 
interventions. Resistance to insecticides and drugs might in the future once again challenge 
the now still effective treatments and interventions. WHO stresses that more efforts and more 
resources will be needed to maintain the gains in the fight against malaria so far and to ensure 
further successes. (17) 
 
 
 
 
14 
 
Zanzibar  
General information about Zanzibar 
Tanzania in east-Africa consists of two semi-autonomous regions, Tanganyika which is the 
mainland and Zanzibar, an archipelago of islands in the Indian Ocean. Zanzibar’s two larger 
islands are Unguja, main island and Pemba, both about 25-50 km from Tanzania mainland. 
The total population of Zanzibar as of latest census in 2012 is about 1.3 million with an GDP 
per capita of $656. Zanzibar, being just south of the equator has a hot climate year around. 
Hottest period is December to March. There are two rain seasons, a short period in November 
-December and the main period in March-May. The administrative divisions of Tanzania and 
Zanzibar is into districts and local wards, shehias. (18) 
History of malaria control in Zanzibar 
Zanzibar have had earlier attempts for control and elimination of malaria with varying 
outcome. In the 1960s Zanzibar benefited from an effective control program, started in 1958 
and between 1961-1968 expanded to be included in the WHO GMEP. In 1968 the prevalence 
had decreased markedly on both islands and as malaria was no longer considered a health 
problem the program was abandoned. Malaria resurged rapidly and by 1980 it was the major 
cause of child mortality. A new major attempt to control malaria started in 1981 but faced a 
difficult challenge and was hindered by shortcomings. Among the difficulties there were 
disorganized interventions of IRS, low levels of public compliance, insecticide resistance and 
suboptimal recruitment of expertise. The spread of chloroquine resistance was also one of the 
major causes to the resurge of malaria and in 2003 there was a 60% failure rate of treatments. 
Malaria has been Zanzibar’s number one public health problem in modern times and in 2003 
accounted for 47% of all outpatient consultations at health facilities and was the disease of 
highest morbidity and mortality.(19) 
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Achieving effective malaria control 
Zanzibar used to be a moderate- to high transmission area but has since 2003 had great 
success in controlling malaria. Among the most important tools were the introduction of ACT 
treatments in 2003/2004, followed by rapid diagnostic tests (RDTs and vector control (VC) 
measures of long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) in 
2005/2006. The implementation of modern interventions and strategies lead to a pronounced 
decline in malaria between 2004-2007 followed by a steady-state of low transmission. (20) 
ZMCP to ZAMEP 
With substantial progress in malaria control, Zanzibar Malaria Control Program (ZMCP) 
2009 conducted a report, assessing the feasibility of reaching malaria elimination.  
The modelling used by ZMCP to estimate the time frame for a potential successful 
elimination highlighted the importance of sustained sufficient uptake and use of vector 
coverage (VC) and proposed that with a 75% coverage elimination could be achieved around 
year 2020. One limitation mentioned of the modelling was that it simplified Zanzibar as a 
closed system, not considering the imported cases that could be of notable proportions. 
Further reasoning suggests that to confidently predict future progress in elimination, 
estimating and handling imported malaria cases is one of the most important factors.(21) 
ZMCP conducted a programme reorientation in august 2013, becoming Zanzibar Malaria 
Elimination Programme (ZAMEP). (20) 
Current malaria situation in Zanzibar 
The public health impact of the interventions and efforts in Zanzibar has been substantial. By 
2015 the P. falciparum prevalence with mRDT was 0.43%, down 96% since 2003. With the 
most pronounced reduction between 2003-2007, thereafter a steady state of low transmission. 
(20) 
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Malaria is since a few years under good control in Zanzibar for the first time since 1968. Yet 
with lower endemicity and exposure, natural immunity will be reduced and future generation 
will be more vulnerable to epidemics.(19) In 2015 there was observed an increased proportion 
of clinical malaria cases among patients >5 years, eventually as a result of lower 
immunization. The age shift could also be explained by behavioural factors affecting risk of 
mosquito bites, such as staying more outdoor at night or less use of LLIN and differences in 
travel frequency to mainland Tanzania.(20) 
It has been appointed that earlier attempts at reducing malaria in Zanzibar likely failed 
because of inconsistencies in the efforts and that due to the nature of the disease in these 
settings, therefore all attempt must be followed by continuous activity to not fail. A powerful 
analogy is that malaria interventions should be considered a standard public health 
intervention, just like vaccinations, and to be continued even with low prevalence, to sustain 
low transmission. (22) 
Once the major reduction is achieved in a region it can be a challenge to maintain the funding 
for malaria control. Some argue that the value of investment in sustaining low transmission 
should be weighted in the benefits of prevented death and morbidity, rather than the further 
achievements of reducing remaining cases. E.g. in Zanzibar it’s estimated that in each year 
660’000 malaria cases and 3300 deaths are averted, to a cost of $1183 per death prevented 
and $34.5 per disability-adjusted life year averted (DALY). (22) 
Zanzibar today represents an example of a high endemic region in sub-Saharan Africa 
achieving pre-elimination and could hopefully within 10 years provide the example of proof 
of elimination concept in such settings. Important factors to the success so far has been the 
high community uptake and high level of organization, made possible by sufficient funding 
and dedication of the people.(20) 
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Malaria surveillance systems in Zanzibar 
Surveillance of malaria is crucial in an elimination program. A robust and sensitive 
surveillance system aims to detect and report all cases of malaria to discover ongoing 
transmission, local foci and imported cases. The collected information is used both for 
interventions and future planning. Appropriate investigation and follow-up of individual cases 
could hopefully lead to rapid detection of imported malaria cases and outbreaks and enable 
targeting of counter-measures.(23)  
Two central parts of the malaria surveillance system in Zanzibar are the Malaria Early 
Epidemics Detection system (MEEDS) and the Malaria Case Notification system (MCN).  
In Zanzibar’s health care system, there is a surveillance and response plan including a passive 
and an active detection system for malaria cases.  
The passive detection system reports all patients seeking a health care facility with clinical 
features of malaria. They are classified as negative or positive to malaria infection using 
mRDT or microscopy blood smear (BS) and the results are registered in the Malaria Early 
Epidemics Detection System (MEEDS) database. The positive tested are interviewed at the 
health facility (HF) using a questionnaire including relevant information such as recent travel 
history, ITN use, last date IRS performed, contact information, sex, age and more. All 
positive tested are reported to a reactive case detection (RACD) program that register 
information to the malaria case notification (MCN) database.   
In the RACD screening an District Malaria Surveillance Officer (DMSO) will routinely start 
an investigation including screening of family household members and in some cases also 
neighbors in a defined area around the index case for malaria. In addition to testing for 
malaria the RACD includes all tested to answer to a questionnaire similar to that used at the 
HF. A difference is that in the RACD screening both negative and positive tested do the 
questionnaire in contrast to at the HF where only confirmed malaria positive partake, offering 
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limited information about risk factors for negative tested at HF level. MCN data includes 
results from the questionnaire protocol but also the number of screened around index case, 
number of positive cases and proportion tested positive. (23) 
Diagnostics in Zanzibar 
In Zanzibar, the standard diagnostic test at a health facility is mRDT, showing relatively low 
sensitivity (79%) but high specificity (99%) as of latest assessment with PCR. The detection 
limit of mRDT is approximately 100 parasites/µL, i.e. equal to that of estimated detection 
limit of blood smear (BS) microscopy in low-income countries. A shortcoming of these 
detection limits is that neither BS nor mRDT allow reliable detection of low density 
parasitemias in asymptomatic individuals that therefore continue to be potential reservoirs for 
malaria transmission. PCR is the most sensitive method, detection limit 0.05-10 parasites/µL 
and can also identify all different species of malaria. On the downside, PCR is expensive, 
takes longer time for result, requires advanced equipment and trained personnel. Considering 
above mRDT might not be optimal for malaria diagnosis in the settings of Zanzibar but PCR 
is not suitable for routine malaria case management in these settings. (24)  
Using mRDT in screening purposes is convenient and inexpensive but considering above 
addressed low sensitivity and relative high detection limits affects the efficacy in use as 
screening, especially if low density parasitemia. 
Risk factors for malaria 
Risk factors of clinical malaria episode in Zanzibar were assessed in 2015. The synthesis of 
the results showed that for risk factor not sleeping under LLIN odds ratio (OR) 3.8 (3.2-4.5), 
not having done IRS recently not significant, travel outside Zanzibar OR 70 and reported by 
49% of all clinical malaria cases, higher OR for females. However, for asymptomatic, PCR 
verified infections none of above risk factors were found significantly associated to higher 
risk of infection.(20) 
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Import of malaria 
As 49% of symptomatic malaria cases in 2015 had recent travel outside of Zanzibar and OR 
of 70 for travel outside Zanzibar clearly points out the importance of effectively limit the 
number of imported malaria in the pursuit of eliminating malaria.(20) 
The feasibility report of ZMCP in 2009 concludes that the efforts in achieving sustainable 
control and elimination of malaria will be influenced by the level of importation risk.  
As Zanzibar is composed of islands relatively far of the coast infected human hosts are 
considered to be accountable as source for the vast majority of all imported malaria, infected 
mosquitos almost neglectable. Further to appreciate the risk and amount of import several 
factors are worth considering. The number of people entering Zanzibar by all means of travel 
combined with the risk profile for being infected and the length of stay in Zanzibar will all 
affect the import of malaria to Zanzibar and further transmission. Risk of being infected vary 
with area of prior stay and length of stay. Residents of Zanzibar travel mainly to Tanzania 
mainland and which area visited will affect the risk of acquiring an infection. (21) 
Receptivity and vulnerability 
Two terms of interest when discussing imported malaria are vulnerability i.e. the risk of 
malaria importation and receptivity meaning the level of transmission. (21) The impact of 
import depends on the local conditions of transmission, such as climatic and vector factors. 
To quantify receptivity the effective reproduction number, Rc is used. Rc weigh in vector 
control measures and estimates the number of secondary infections from one untreated 
case.(25) 
A study using mobile phone data to quantify the risk and significance of imported malaria to 
Zanzibar suggested that residents of Zanzibar travelling to malaria endemic regions contribute 
the most to import and that imported malaria greatly sustains and adds to the local 
transmission. In fact, the authors propose that with sustained levels of control measures the Rc 
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would be < 1 in most areas if there would be no imported malaria. This would mean that 
without import of malaria, elimination would be achievable for most areas of Zanzibar.(25) 
This has however been questioned by other research, supporting that there is a considerable 
import of clinical malaria, even likely increasing, but less than above modelling suggests.(20) 
Sinks and Sources 
Areas that are net emitters (“sources”) and areas that are net receivers (“sinks”) of malaria can 
be described. Identifying sources and sinks could possibly allow for targeted control in areas 
where imported infections originate or where they contribute significantly to transmission and 
can improve malaria control programs.(26) 
Residents of Zanzibar travelling and returning contribute 1-15 times more to import of 
malaria than infected visitors.(25) Mainland Tanzania has been identified as the major source 
of malaria importation to Zanzibar. Considering the combination of travel destination risk 
profile (dEIR or other estimate), length of stay and other factors have concluded that a key 
group of few people contribute for most of the imported malaria to Zanzibar. (21) 
Tanzania mainland has been found to have higher malaria risk compared to Zanzibar, due to 
both higher EIR and vulnerability. The malaria risk of different areas in in the mainland is 
very heterogenous. The variation is mostly attributable to variations in EIR, showing less tie 
to the level of vulnerability, which is relative high for most regions of mainland. (27) 
The coverage of interventions like vector control and ACT treatment in the mainland likely 
have a significant effect on the numbers of imported cases to Zanzibar. Future control efforts 
in the mainland could possibly further greatly reduce the numbers of imported cases.(21) 
Imported malaria can only contribute to further transmission if the local conditions support 
transmission. The receptivity is affected by factors like VC coverage, level of local 
transmission and vector population. 
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Possible actions of control programs to counter imported malaria might be to educate about 
risk of travel, how behaviour affects the risk and to routinely target surveillance strategies to 
high-risk areas. (26) Other possible measures of action could be to hand out 
chemoprophylaxis or screening of travellers. (25) 
Challenges and future strategies in Zanzibar 
Some of the major challenges for further progress towards malaria elimination in Zanzibar are 
a substantial asymptomatic parasite reservoir, changes in vector species and biting behaviour, 
insecticidal resistance and imported malaria cases. Also continued sufficient funding, high 
uptake of interventions, preserved efficacy of treatment and persistence in fighting resurgence 
is likely needed for longstanding successful outcome. 
A significant number of asymptomatic malaria cases has been observed in cross-sectional 
studies in two districts of Zanzibar, showing that earlier estimates of incidence could be 
underestimates. Estimates based on epidemiological data suggest that rather than the 
approximately 3000 clinical malaria cases the actual incidence is over 10´000 cases yearly, 
when including asymptomatic cases.(20) 
Screen and treat in Zanzibar in current settings hasn’t proved effective, partly due to low 
sensitivity of mRDT in low density parasitemia. New highly sensitive diagnostics for mass 
screen and treat (MSAT) or mass drug administration (MDA) has been suggested as 
alternative strategies to get hold of the asymptomatic infected individuals. An asymptomatic 
individual poses a risk for further transmission and could fuel the ongoing transmission.(28)  
To address the challenges new tools are suggested to intensify the control and efforts in 
eliminating malaria in Zanzibar. This could include new highly sensitive screening methods 
or different targeting of treatment. Supplemental treatment strategies could be mass drug 
administration (MDA) and / or seasonal chemoprevention. Case detection might need 
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improvements and new approaches to prevent secondary transmission, especially considering 
imported cases. (20) 
A MDA pilot project has been conducted in Zanzibar showing promising outcome. The pilot 
project has been followed up by a study of MDA treatment in 3 districts of Zanzibar, results 
are still being analysed. (Morris et al, unpublished)  
Extended collaboration between different neighbouring regions could also reduce risk of 
imported malaria and reinforce the local achievements. Zanzibar would likely especially 
benefit from reductions of local transmission of malaria in Kenya and mainland Tanzania. 
(21) 
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Aim of the study  
To describe characteristics of clinical malaria patients in Zanzibar during 2016, and especially 
to assess travel to mainland Tanzania as a risk factor. 
Specific aims 
Primary aims 
• To assess reports of travel outside Zanzibar one month before malaria diagnosis as a 
risk factor for imported malaria 
o To assess the spatial distribution of locally infected vs. travel malaria cases 
o To assess the temporal trends of malaria transmission among locally infected 
vs travel malaria cases  
o To address if there is any sign of clusters of cases following initial imported 
cases  
▪ to assess frequency of testing positive for malaria among patients 
screened in MCN RACD  
o To assess age and sex distribution of travel vs non-travel cases 
Secondary aims 
• To compare the proportion of LLIN/IRS coverage among locally infected patients vs. 
patients with history of travel to/from Zanzibar during the past 30 days (travel 
patients) 
• To present descriptive frequencies of travel destination areas outside Zanzibar 
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Material and Methods  
Study design 
This was a retrospective, descriptive and case-control study using quantitative data from a 
malaria surveillance database. Supplementary data has to some extent been obtained from 
other data sources to create a context of presented information, make comparisons and to aid 
in reasoning of conclusions and implications. 
Study population 
The study population consisted of all passively and actively detected malaria cases1 in MCN 
database, i.e. from health facilities and from case follow-up, re-active case detection (RACD) 
screening. The limited data available for negative tested for those in RACD screening was 
also included. Period for inclusion was whole year of 2016. All areas of Zanzibar were 
included, both Unguja and Pemba. 
Inclusion criteria’s 
• Symptomatic malaria case testing positive at health facility or screened individuals in RACD 
follow-up 
o Confirmed P. falciparum or other species of malaria by mRDT or microscopy 
• Available data registered in MCN or MEEDS database 
Exclusion criteria 
• If missing information in questionnaire at health facility or RACD screening for a specific 
variable that case was excluded from the analysis 
 
                                                 
1 Symptomatic malaria cases confirmed by mRDT or microscopy 
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Data collection 
Surveillance data from MCN and MEEDS systems were provided by ZAMEP (29) and 
converted to Microsoft Excel files.  
MCN data 
The data from MCN database includes information about malaria positive at health facilities 
and positive and negative RACD screened. 
In the registered information of the databases malaria positivity was confirmed by mRDT or 
microscopy and all other information was obtained from questionnaires. 
Of total 3816 malaria cases detected at health facilities in 2016, data for 2534 (66%) were 
reported into the MCN system for follow up. Cases were included in an analyse if they had 
the sought information registered from the questionnaire, see table 1 for availability by 
variable. If the questionnaire was not fully entered into the database a case could sometimes 
be used in one situation but not in another. Due to the varying availability of information this 
sometimes led to different numbers of cases included in different data sets and comparisons.  
This approach ensured highest possible number of cases included in each analysis. This study 
was not set out to evaluate the surveillance systems of Zanzibar and therefore assumes that the 
difference in sampling will be random and not greatly affect the results. Cleaning of the data 
was done to match inclusion and exclusion criteria. 
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Table 1. Showing coverage of data available in MCN database for malaria positive at health facilities 2016. Not considering 
eventual inclusion / exclusion criteria’s. 
Variable available data1 %/nr 
Recent travel history 97% / 2462 
LLIN last night 85% / 2149 
Date of IRS 74%/ 1874 
Age 97% / 2463 
Sex 97%/ 2462 
District 100% / 2522 
MCN cases 2534 
All malaria cases
2 3816 
1 Of MCN cases followed-up with available questionnaire results in database 
2 Symptomatic cases at HF, confirmed positive 
Definitions and details of variables 
“Malaria positive” refers to symptomatic malaria cases confirmed positive by mRDT testing 
or microscopy for P. falciparum infection or other malaria species. The malaria cases were 
from MCN data, including both detected at health facilities or in follow-up screening RACD. 
“Recent travel history” was defined as having travelled outside of Zanzibar in the recent 30 
days.  
“Travel destination” was reported in the HF questionnaire by those with recent travel history. 
If multiple recent travel destinations only the most recent destination was considered.  
“IRS done recently” is defined as within 8 months (240 days), in accordance to recent 
research about resistance to insecticides in Zanzibar (30) and WHO recommendations of 
adequate residual efficacy of  >80% mosquito mortality within 24 hours(31). If IRS was done 
more recent than within 2 recent weeks these cases were excluded. These cases were excluded 
to be able to more accurately distinguish if a case had effective IRS coverage or not, taking 
into account a normal incubation period of malaria of about 14 days.  
LLIN usage was assessed as having slept under LLIN or not the night prior to being screened 
or visiting HF. 
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Supplemental data 
Rainfall data was obtained from “Zanzibar Malaria Elimination Programme”(29), Malaria 
prevalence data of mainland district from “Tanzania Demographic and Health Survey and 
Malaria Indicator Survey”, 2015-2016(32). 
Background information on malaria and Zanzibar from various sources, see references in text. 
Statistical analysis 
Data from MCN database was cleaned using Microsoft Excel 2016. Descriptive statistics was 
used to summarize and present outcome variables using Microsoft Excel 2016. Statistical 
analyses were performed for CI 95% and statistical significance p<0.05 using MedCalc for 
Windows, version 15.9.7 (MedCalc Software, Ostend, Belgium). Calculations were done for 
unadjusted OR’s, RR, test for one proportions and comparison of proportions ("N-1" Chi-
squared test). 
Calculation of OR for travel 
Data on malaria positive2 cases from HF were obtained from the MCN database. Data on 
malaria negative3 controls were from a MDA study survey (Morris et al, unpublished), for 
two different periods during 2016. MDA survey data were used for controls as there were no 
data available for malaria negative at HF.  
Matching for geographic areas and time periods were done for the surveys and the MCN data. 
MDA data included some shehias and MCN data included all shehias for the same districts. 
MCN data included all shehias to ensure enough cases for a case-control. To assess if the 
MDA shehias could be considered representable for the whole districts in a case-control 
                                                 
2 Confirmed positive by mRDT or microscopy 
3 Confirmed negative by PCR 
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analysis a comparison of the MDA and non-MDA shehias was done. MCN data was used to 
assess if there was a significant difference in proportions reporting recent travel in malaria 
positive in MDA shehias vs non-MDA shehias during 2016, using "N-1" Chi-squared test. 
Ethical consideration 
For a patient to be included in MEEDS and MCN databases informed consent is not a 
requirement. By seeking health care, patients accept registration in medical health system and 
to be asked relevant questions. Choosing to not seek health care for the sake of not wanting to 
be included in MEEDS database was considered unlikely and was not taken into 
consideration. No person was put at risk during the study and all data used was already 
registered. No identification of individual persons from database is possible in results after 
data is cleaned and analyzed. Findings of the study could potentially benefit ZAMEP and 
therefore the spent time of personnel assisting was considered a reasonable investment of 
resources.   
Results 
Testing rate and findings 
As seen in Table 2, a total of 4181 confirmed symptomatic malaria cases were detected in 
Zanzibar in 2016, this figure includes all cases at HF and during RACD screening. At HF 
3816 cases were detected, testing rate 0.26. In RACD case follow-up screening another 365 
cases were detected. Testing rate of the whole population of Zanzibar when summarizing HF 
tests and RACD screening tests was 0.22, same person tested more than once possible. 
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Risk factors at HF 
The results show that among those tested positive for malaria at HF 48% had recent travel 
history outside Zanzibar within 30 days, 31% lived in a house which interior walls had been 
treated with IRS within effective interval and 64% had slept under LLIN the prior night. 
Table 2. Presenting numbers of Zanzibar’s population, malaria in Zanzibar and findings of the active and 
passive detection of malaria in Zanzibar’s health system. 
Zanzibar population 
 
Health facility 
attendees 
 
RACD screen   
Total population 1467477 Total health facility 
attendees 
1239180 Total intended to screen 8746 
Total tests for malaria1 325514 Total tested 317013 Tested 8501 
Total testing rate per 
resident
2 
0.22 Testing rate 0.26 Testing rate 0.97 
Total malaria positive
3 4181 Total positive 3816 Positive 365 
Cumulative incidence, 
per resident per year 
0.28% Positivity rate 0.012 Positivity rate 0.043 
  
 
Positive - with travel 
history recent month 
48% Positive with recent 
travel history4 
71% 
  
 
Positive - IRS done 
recently (<8 months) 
31% Total index cases 2534 
  
 
Positive - LLIN usage 
(slept under last night) 
64% 
 
  
    MCN reported 2534     
1 Including at HF and RACD 
2 
Including at HF and RACD
 
3 
Microscopy or mRDT confirmed, including cases detected at HF and in RACD 
4 Only available and included for period January 1 – February 8, 2016 
 
Travel as risk factor 
Unadjusted ORs for recent travel as risk factor 
Reported recent travel within 30 days outside Zanzibar as risk factor for testing positive for 
malaria is displayed in Table 3. The proportion reporting recent travel history among malaria 
positive at HF where found to be 51% during MDA baseline, 55% during MDA follow-up 
and 61% for the whole year of 2016. The proportion reporting recent travel among malaria 
negative were found as 0.3% at MDA baseline and 0.4% at MDA follow-up.  
30 
 
Recent travel was found to be a highly associated risk factor for malaria with statistical 
significance for all periods included. 
Table 3. Presentation of unadjusted ORs for recent travel outside Zanzibar as risk factor for malaria. Travel in symptomatic 
cases of malaria (collected in the MCN database, confirmed positive by mRDT at HF) was compared against travel in 
malaria negative individuals (collected during cross-sectional surveys, confirmed negative by PCR) (Morris et al, 
unpublished). Data are matched by district and date (survey period), but not for age. 
 
Malaria positive 
cases 
MCN data 
Period 
Malaria negative 
controls  
Survey data 
-Period 
Cases travel  
% (n/N) 
Controls 
travel  
% (n/N) 
OR CI Significance level 
 
Same as MDA 
baseline 
MDA baseline1 
 
51% (34/67)  0.4% 
(33/7789) 
222 124-397 P < 0.001 
 
Whole 2016 
  61% 
(511/841) 
 0.4% 
(33/7789) 
334 234-476 P < 0.001 
 
Same as MDA 
follow-up 
MDA follow-up2 
  
55% (11/20)  0.3% 
(31/9762) 
384 149-991 P < 0.001 
 
Whole 2016 
  61% 
(511/841) 
 0.3% 
(31/9762) 
486 333-710 P < 0.001 
1 MDA baseline – 30/4-15/5 2016, West, Central and South district. 
2 MDA follow-up – 27/8-9/9 2016, West, Central and South district. 
See appendix for calculations and assessment of comparability between the different sources of data for cases 
and controls. 
The different sources of data for malaria positive and negative were assessed for fitness of use 
in comparison above. In the travel data from malaria positive cases there was no significant 
difference between the data collected in Shehias included in the malaria negative data, and the 
Shehias that were not included (P =0.1), indicating that the malaria negative data is 
representative of the whole shehias.  See table 2.1 in appendix for comparison of shehias. 
Interannual trend in travel 
As seen in Table 4, in 2016 the distribution of all tested positive for malaria at health facilities 
reporting recent travel outside Zanzibar within 30 days was 48%. The interannually trends for 
2013-2016 displayed in Table 4 shows that from 2013 to 2015 the distribution of cases 
reporting recent travel history increased from 31% to 53%, then in 2016 back to 48%. 
Reported travel only within Zanzibar was differing from 0.2% in 2013 to 5% in 2014, for 
2016 3.6%. 
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Table 4. Showing recent travel history for malaria positive in MCN data 2013-2016. Absolute numbers and % presented. 
 
No 
travel 
 
Travel outside of 
Zanzibar 
Travel within 
Zanzibar 
 
Total Nr Total % 
Year Nr % Nr % Nr % 
  
2013 1392 69.0% 623 30.9% 4 0.2% 2019 100.00% 
2014 1884 59.7% 1116 35.4% 157 5.0% 3157 100.00% 
2015 1655 43.1% 2045 53.2 % 142 3.7% 3842 100.00% 
2016 1191 48.4% 1183 48.1 % 88 3.6% 2462 100.00% 
Grand 
Total 
6122 53.3 % 4967 43.3% 391 3.4% 11480 100.00% 
 
Temporal trends 
As can be seen in Figure 1 in 2016 there were two peaks of malaria incidence in Q1 and Q2, 
the one in Q2 coinciding with the normal yearly peak of transmission in Zanzibar. The 
proportion of malaria cases reporting recent travel outside Zanzibar varied by month, from 
lowest 37% in May to highest 71% in October.  
During peak malaria transmission season both total number of malaria cases increased and the 
absolute number of malaria cases with recent travel. During the normal peak malaria 
transmission season in Q2 the total number of malaria cases increased more than the cases 
reporting recent travel, resulting in a lower proportion with recent travel history for that 
period. On the contrary, in relative low season for malaria transmission in Q3-Q4 the 
proportion of malaria cases reporting recent travel history peaked in proportion. 
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Figure1. Presentation of temporal trends in travel in relation to rainfall and time of year. Malaria positive in MCN data for 
health facilities. 
Demographics 
A seen in Figure 2, a large proportion of all malaria cases were in ages 10-29 years and fewer 
cases in the youngest (0-9 years) and above 30 years age. The proportion reporting recent 
travel in different age groups varied. The highest proportion reporting recent travel were in 
ages 20-50 in both sexes. 
There were more malaria cases testing positive among males than among females 
(1408/1042). Number of cases with reported recent travel history were almost equal among 
sexes, male 47% and female 49% (difference 2%, CI -2 to 6, p=0.33). 
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Figure 2. Showing recent travel history for malaria positive by sex and age grouping. Absolute numbers presented as bars 
and proportions as lines. Malaria positive in MCN data for health facilities. 
Vector coverage 
As seen in Table 5, vector coverage among malaria positive at HF was overall less for IRS 
than for LLIN. Vector coverage varied whether they had recent travel history or not, LLIN 
higher coverage if recent travel history than if not, 68% vs 61% (difference 7%, CI 1.9-12, 
p=0.007) and IRS less coverage if recent travel history 29% vs 33% (difference 4%, CI -4,4-
12.1, p=0.35).  
 
Table 5. Coverage of IRS and LLIN by recent travel history, all ages and sexes. Displayed as % of row and (nr). Malaria 
positive at HF in MCN data. 
Travel history  Slept under LLIN last night     IRS recently   
  No Yes   No Yes 
No travel 39% (459) 61% (711)   67% (600) 33% (292) 
Yes travel 32% (308) 68% (657)   71% (493) 29% (203) 
Total 36% (767) 64% (1368)   69% (1093) 31% (495) 
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Vector coverage by district  
Table 6 shows variation by district in usage of LLIN the night before testing positive. 
Micheweni district had the lowest proportion of malaria positive reporting use of LLIN last 
night, and highest proportion in Magharibi district.  
Table 6. Districts sorted by lowest coverage of LLIN. Malaria positive in MCN data for health facilities. 
 
Used LLIN last night before 
testing positive for malaria 
   
 
No 
 
Yes 
 
Districts % Nr % Nr 
MICHEWENI 56% 240 44% 189 
KUSINI 40% 35 60% 52 
KATI 36% 105 64% 188 
CHAKE CHAKE 35% 20 65% 37 
MKOANI 33% 27 67% 54 
KASKAZINI B 31% 95 69% 209 
MJINI 29% 64 71% 156 
WETE 29% 45 71% 111 
KASKAZINI A 28% 45 72% 118 
MAGHARIBI 25% 85 75% 253 
Grand Total 36% 761 64% 1367 
 
The IRS coverage by district presented in Table 7 shows that overall there was a low coverage 
of IRS, just 31% of all malaria positive at HF had done it within effective interval of <8 
months. Coverage varied greatly between districts, in Chake Chake 100% had not done IRS 
<8 months compared to Kusini, 57% had done it.  
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Table 7. Districts sorted by lowest coverage of IRS. Malaria positive in MCN data for health facilities. 
 
IRS within 8 months  
  
 
No  Yes  
Districts % Nr % Nr 
CHAKE CHAKE 100% 57 0% 0 
MKOANI 100% 1 0% 0 
MJINI 96% 85 4% 4 
WETE 90% 54 10% 6 
MAGHARIBI 74% 189 26% 67 
MICHEWENI 71% 294 29% 123 
KASKAZINI A 64% 101 36% 57 
KATI 63% 128 37% 76 
KASKAZINI B 55% 145 45% 117 
KUSINI 43% 33 57% 43 
All districts 69% 1087 31% 493 
 
Sources and sinks 
Sources 
51 different travel destinations were in total reported by malaria positive with recent travel 
history outside Zanzibar. Tanzania mainland was reported as travel destination by 94% of all 
travel cases. Top ten reported destinations were all districts of the mainland, reported by 81% 
of total. 
As displayed in Figure 3, Dar es Salaam district was the top reported destination, reported by 
30% of the travel cases. As comparison district Morogoro was reported by 10%, districts 
Lindi and Kigoma each reported as travel destinations by 2% of all. 
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Figure 3. Top ten travel destinations of total 51 different destinations reported. Showing count and proportion of 
destinations. Line showing % of total malaria cases with recent travel history. Malaria positive in MCN data for health 
facilities. 
Sinks 
As seen in Table 8, the proportion of malaria positive reporting recent travel history outside of 
Zanzibar or not varied greatly by district. Mjini district, the city area of Stone Town, had the 
largest proportion reporting recent travel in comparison to Micheweni district with the lowest, 
80% vs 6%. 
Table 8. Showing distribution of recent travel history in malaria positive, by district. Sorted by largest to smallest proportion 
with recent travel. Malaria positive in MCN data for health facilities. 
 
Travel history 
    
 
No travel 
 
Yes travel 
 
Total Nr Total % 
District Nr % Nr % 
  
MJINI 64 20,00% 256 80,00% 320 100,00% 
MAGHARIBI 126 30,51% 287 69,49% 413 100,00% 
KASKAZINI A 54 30,68% 122 69,32% 176 100,00% 
CHAKE CHAKE 25 36,76% 43 63,24% 68 100,00% 
KATI 149 45,29% 180 54,71% 329 100,00% 
KUSINI 55 55,56% 44 44,44% 99 100,00% 
KASKAZINI B 196 56,48% 151 43,52% 347 100,00% 
WETE 118 72,84% 44 27,16% 162 100,00% 
MKOANI 75 79,79% 19 20,21% 94 100,00% 
MICHEWENI 412 94,28% 25 5,72% 437 100,00% 
All districts 1274 52,11% 1171 47,89% 2445 100,00% 
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RACD 
RACD risk factors 
As shown in Table 2, 365 malaria cases were detected by the active follow-up of index cases 
detected at health facilities. As seen in Table 9, 71% of those found positive reported recent 
travel. The reported LLIN usage the night before testing positive was 56%. IRS data not 
available. 
Table 9. Figures for presence of risk factors in RACD screen for those who tested positive for malaria.  
  Yes 
 
No 
 
Total 
Risk factors Nr % Nr %   
LLIN used last night 206 56% 159 44% 365 
RACD screened, recent travel history
1
 73 71% 30 29% 103 
1
 Only available and included for period January 1 – February 8, 2016
 
As seen in Table 10, not having used LLIN showed to be a significant risk factor for those 
screened in RACD, unadjusted OR 1.6 (P<0.001, CI 1.3-1.9). Travel outside Zanzibar in the 
recent 30 days was also found to be a significant risk factor for those positive in RACD, 
unadjusted OR 21.8 (CI 13.8-34.6, P<0.001). Information regarding IRS was not available. 
Table 10. Showing risk factors for malaria in RACD screened quantified by unadjusted ORs. 
Variable OR CI Significance Nr (total) 
LLIN not slept under last night 1.6 1.3-1.9 P<0,001 159 (365) 
Travel outside Zanzibar in recent 30 days1 21.8 13.8-34.6 P<0,001 73 (103) 
1 Only available and included for period January 1 – February 8, 2016 
RACD positivity rate by index case recent travel history 
As seen in Table 11, there was a higher positivity rate in the RACD screened who had index 
cases with recent travel history, 6.8% vs 2.6%. RR 2.7 (CI 95% 2.2-3.3, p<0.001) for RACD 
screened with index case with recent travel history vs no recent travel history. 
Table 11. RACD screening positivity rate by index case recent travel history.  
Recent travel history for index case of RACD screened Screened Positive Positivty rate 
No travel outside Zanzibar 4805 123 2.6% 
Yes, travel outside Zanzibar 3436 235 6.8% 
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Discussion and conclusions 
Imported malaria has been suggested to contribute to sustained local malaria transmission in 
settings of low transmission like in present Zanzibar.(20, 21, 25, 33) Not using LLIN or not 
having done IRS recently has earlier been found to be associated with increased risk of being 
infected with malaria in Zanzibar.(20) 
The findings of this study explore characteristics and risk factors such as recent travel history, 
use of vector control, age, sex, temporal trends and seasonal variations for confirmed malaria 
cases in 2016 in Zanzibar.  
Demographics 
A relative shift in malaria towards older age groups has earlier been reported in Zanzibar. In 
year 2002 47% of all malaria in two studied districts was among <5 years of age, for 2015 
17%. (20) The results of this study support that there has been an age shift, showing that 
malaria was found in relatively high proportions in adults. The observed age shift might be 
explained by a presumed lower malaria immunity in the general population as a consequence 
of the lowered malaria transmission.(34) Malaria cases in age 20-50 years had a relatively 
high proportion reporting recent travel history, which might have contributed to the relatively 
many malaria cases in adults. 
The higher proportion of malaria cases among men, 57% vs 43% for women might be 
partially explained by behavioural factors. Men had a slightly higher proportion of malaria 
cases reporting recent travel history 49% vs women 47%. The proportion of men reporting 
recent travel was slightly higher but more information regarding travel statistics for the 
39 
 
population, outdoor activities, differences in vector coverage etc would likely be needed to 
explain the difference.  
Travel as risk factor 
That a proportion of 48% of all malaria positive at HF reported recent travel imply that a large 
portion of all symptomatic malaria cases were imported.  
As expected recent travel proved to be a significant risk factor for malaria at HF. The 
unadjusted ORs for different periods, ranging 222-486 were quite high compared to earlier 
findings of adjusted OR of 70 for clinical malaria cases in Zanzibar 2015. (20) There were 
however several differences in the data used for calculations, for example the use of adjusted 
OR and different areas and time periods used.  
The OR for MDA follow-up period Q3 was higher compared to OR for MDA baseline Q2. As 
seen in Figure 1 this corresponds to the relative higher proportion reporting recent travel 
history in Q3-4 compared to Q1-2. The variation in proportion of travel cases and non-travel 
cases could likely partly be explained by the known seasonal variation in local transmission, 
mainly related to rainfall and vector capacity. To further assess other factors affecting the 
seasonal variation in proportion travel cases, information regarding seasonality of malaria 
transmission in Tanzania mainland and travel statistics for malaria negative or general 
population would be relevant. There might be seasonal variation in both travel behaviour and 
risk associated with travel as earlier theorized.(21)  
Interannual trends 
In 2010 the proportion with recent travel history was 7%, OR 9. (35) For 2013 to 2015, as 
seen in Table 4 there seems to have been a continued trend of an increased malaria positive 
reporting recent travel history. This might indicate an actual increase in proportion of 
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imported malaria cases vs locally infected in Zanzibar. If this assumption is correct it would 
imply that for further achievements in controlling and eliminating malaria in Zanzibar the 
control of imported malaria is growing increasingly important as it has been suggested it 
would do.(21) In 2016 there was a slightly lower proportion of travel cases but when 
considering the whole period 2013-2016 the trend has been towards an increased proportion 
with travel history. The period observed is quite short and to compensate for yearly variations 
due to natural variation and errors of database it would be useful to expand the time period by 
including earlier years and to continue follow the trend in coming years.  
Sources and sinks 
Sources 
As concluded in the results a clear majority, 94% of all travel outside Zanzibar reported by 
malaria cases was to Tanzania mainland. That the top ten travel destinations reported cover 
81% of all patients with recent travel history suggests that there are a few destinations in the 
mainland attributable for the vast majority of imported malaria to Zanzibar. Focusing on key 
regions might give insight were and how interventions might be best introduced. 
Different districts of mainland Tanzania has different epidemiology of malaria and therefore 
likely pose different risk while visiting to get infected by malaria.  
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Picture 2.(32) Showing malaria prevalence by districts of mainland Tanzania, in children age 6-59 months, confirmed cases.  
Two factors that affect the number of imported malaria from different districts of mainland 
Tanzania are epidemiology and volume of travellers visiting. (25),(33), (21) Some districts 
might be possible to consider as key districts for risk of imported malaria. These districts 
would be more suitable for interventions by having a relative high risk profile but also quite 
many travellers visiting. It would probably be more effective to target travellers going to high 
risk areas rather than low risk areas to make an impact on imported malaria from mainland 
Tanzania to Zanzibar.  
Dar es Salaam had the highest number of malaria positive reporting it as recent travel 
destination but a low prevalence of malaria, 30% respectively 1%. Kigoma had relative to Dar 
es Salaam few malaria cases reporting it as travel destination but a high prevalence of malaria 
in the district, 2% and 38%. Morogoro had a combination of reported as travel destination by 
many and a high malaria prevalence, 17% and 23%. Targeting travellers who visited / who are 
going to visit e.g. Morogoro might be easier and more effective than for Dar es Salaam. 
Targeting key traveller groups to limit malaria importation has been proposed by earlier 
studies, e.g. by distribution of chemoprophylaxis, education about risks and protective 
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measurements such as mosquito repellent, covering clothing, not staying out late at night, use 
of LLIN, screening at ports / on ferries or presumptive treatment. (21, 25, 33)  
Sinks 
There was a high variation by district in proportion of malaria cases reporting recent travel 
history. Mjini was the district reporting highest proportion with travel history among malaria 
positive compared to Micheweni the lowest proportion, 80% vs 6%. This difference likely 
presents a corresponding difference in actual proportion of imported malaria. Mjini could 
likely be considered an area of net import of malaria, a sink.  
To further assess sinks of malaria import with higher accuracy could possibly aid in finding 
key traveller groups or give directions how to best prioritize interventions. Targeted recurring 
screenings, education or distributing chemoprophylaxis could be possible interventions. 
Vector coverage 
As seen in Table 5, the IRS coverage of 31% vs 64% for LLIN for malaria positive at HF 
might suggest that there is an overall low effective coverage of IRS in the population 
compared to the uptake of LLIN. After a change of policy in 2012 IRS spraying was no 
longer universal but targeted to focal hotspots. (24) The change of policy led to a decreased 
coverage of IRS, 2008-2011 91% in Micheweni and 85% in Kaskazini A reported having 
done IRS within last year but for 2013-2015 corresponding 79% and 54%.(20) This study 
concluded that among malaria positive in 2016 29% in Micheweni and 36% in Kaskazini A 
reported having done IRS within 8 months, as seen in Table 7. Comparing different years, 
different time periods for IRS coverage and general uptake vs uptake in malaria positive it’s 
still fair to conclude that the effective IRS coverage has continued to remain quite low.  
LLIN/ITN coverage was quite high between 2005 and 2015 in Micheweni and Kaskazini A, 
means of 68% and 74% for all. Children <5 years higher use than individuals >5 years, 81% 
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slept under LLIN/ITN compared to 69%. (20) This report showed that for malaria positive in 
2016 44% in Micheweni and 72% in Kaskazini A had slept under LLIN the night prior to 
testing positive. The uptake of LLIN seemed to be lower among malaria positive in 2016 than 
for the general population 2005-2015 for these two districts. The reported lower use of LLIN 
among malaria positive compared to the general population might give some support that not 
using LLIN is a risk factor for clinical malaria. The earlier reported lower use of LLIN for 
individuals >5 years old compared to <5 years old in 2005-2015 might have affected the 
observed relative high proportion malaria in >5 years old. 
The uptake of vector coverage among malaria positive varied by district, LLIN coverage 
ranged from 75% to 44% and IRS coverage ranged 0% to 57%. A high proportion not covered 
by VC implies that some of the malaria cases might be preventable. Further quantifying 
differences of certain areas in uptake of control measures and the attributable proportion of 
malaria theoretically preventable might aid in prioritizing resources and target areas. For 
example, the low uptake of LLIN in a certain district might prompt education and handing out 
of LLIN to the residents. 
The results showed higher LLIN use (not significant) and lower IRS coverage (significant) 
among travel cases than non-travel cases. The VC coverage for those reporting recent travel 
was not assessed for the travel and therefore the information about their actual VC coverage is 
limited. However, vector control affects the receptivity of malaria and high uptake could limit 
the secondary transmission of imported malaria. (21) 
Future research could assess the use of LLIN during travel, type of accommodation, length of 
travel, use of mosquito repellents and other factors affecting the risk of acquiring malaria 
while travelling.  
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RACD screening of households 
A high proportion of reported recent travel in malaria positive in RACD screening and by HF 
cases could be interpreted as support for that travel is a risk factor for malaria and that family 
members likely have travelled together to some extent. There was observed a clustering of 
secondary transmission around travel cases, in RACD screening positivity rate 6.8% for travel 
cases respectively 2.6% non-travel cases, RR of 2.7. To explain the clustering around travel 
cases more information would be need, such as if the families travelled together, what other 
factors affecting receptivity were present. 
Reported recent travel and not having used LLIN were both significant risk factors for malaria 
in RACD screened. The relative lower reported use of LLIN in RACD positive compared to 
positive cases at HF, 56% vs 64% might also support that not using LLIN is a risk factor for 
malaria. As both malaria positive in RACD screen and at HF reported high proportions with 
recent travel history there was a risk of bias when calculating OR for recent travel as risk 
factor for malaria. Risk of being infected by malaria for household members to a malaria case 
seems to be highly related to recent travel history outside Zanzibar, either by own travel, 
travel of family member or both. A limitation in the assessment of recent travel as risk factor 
for RACD screened was that the data was only available for a short period, 1/1-8/2 2016. 
Methodological considerations 
Symptomatic and asymptomatic malaria 
The confirmed 4181 symptomatic cases of malaria in 2016 should be known to likely be an 
understatement of the actual malaria burden in Zanzibar. It has recently been shown by using 
PCR analysis that there is a large proportion of asymptomatic malaria in Zanzibar.(20) The 
asymptomatic malaria cases might not present similar characteristics as the findings in the 
45 
 
symptomatic cases, making the findings in this study only applicable for a portion of all 
malaria in Zanzibar. 
Malaria testing is mainly done by mRDT in Zanzibar. mRDT has earlier been reported to 
have high specificity but low sensitivity compared to PCR.(24) The low sensitivity might 
suggest that some clinical malaria patients were missed.  
 
MCN database 
As a result of both incomplete follow-up of malaria cases detected at HF’s by DMSO’s and 
errors of the MCN database only 66% of HF cases were reported to MCN, the falling-off was 
likely random. 
As much of the data from the MCN database is based on questionnaires the results could be 
affected by recall bias. 
The missing data in MCN database varied by variable as shown in results Table 1. The results 
might be affected by the incomplete questionnaires and chosen methodology for handling this. 
Although this study was not set out to evaluate the accuracy of the malaria surveillance 
systems and databases of Zanzibar it´s a limitation that that the chosen methodology and data 
available not necessarily ensures highest possible reliability of the results.  
Travel 
Recent travel history reported by a malaria case implies that the patient could have acquired 
malaria during travel. The patient could however also have acquired malaria in Zanzibar and 
therefore this information couldn’t replace what e.g. a PCR analysis of malaria strains could 
tell about the origin of the infection. Actual confirmed imported malaria cases would be more 
accurate to estimate the volume of imported malaria. 
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Limitations of the OR calculations presented in Table 3, are that different sources of data 
were used for malaria negative and positive (sources including different shehias) and that the 
data were not matched by age. As there was found no significant difference in the shehias 
included for malaria negative in surveys and malaria positive in MCN data (see appendix) the 
different sources of information seemed fit to use in absence of alternative options.  
Conclusions and implications 
With high ORs for recent travel as risk factor for malaria and a high proportion of all malaria 
cases reporting recent travel it’s reasonable to assume that imported malaria contributes 
considerably to the malaria burden of Zanzibar. As the clear majority of all malaria cases 
reporting recent travel had travelled to mainland Tanzania it’s reasonable to believe that the 
success in limiting imported malaria cases to Zanzibar could benefit greatly by advances in 
malaria control in the mainland and that it’s in Zanzibar’s interest to promote further 
collaboration. 
Uptake of VC measurements as IRS and LLIN will likely continue to be of importance to 
limit malaria transmission. The observed shift of vector species, the proposed increased 
outdoor biting rate and resistance to insecticides will likely pose challenges.(20) 
This study provides support to earlier study’s findings, proposing that imported malaria plays 
an important role in sustaining malaria in the pre-elimination setting of Zanzibar.  An 
effective approach and strategy to fight imported malaria in Zanzibar would likely aid in 
reaching the goal of achieving elimination. Identifying and targeting key travel groups with 
interventions to limit imported malaria could be a resource-effective strategy. If other data 
would be available, such as general travel data and statistics for each district this could be 
used in a case control analysis and the results likely present more useful quantified risk 
profiles of each districts and attributable numbers. There are also other known variables 
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determining the risk of acquiring malaria while travelling apart from endemicity, such as 
length of stay, type of accommodation, type of traveller typically visiting the area, VC 
availability and usage etc.(21) These data would also be of interest to assess in future 
research.  
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Populärvetenskaplig sammanfattning 
”Resa till Tanzanias fastland som riskfaktor för malaria och 
vidare spridning i Zanzibar 2016” 
Bakgrund: Malariabördan i Zanzibar har historisk varit hög men är nu låg, fortsatt minskning 
och elimination har dock uteblivit. Resa utanför Zanzibar har tidigare identifierats som en 
riskfaktor för malaria i Zanzibar och import av malaria från Tanzanias fastland har föreslagits 
underhålla den kvarvarande malariabördan på Zanzibar.  
Syfte med studien: Att undersöka resa till Tanzanias fastland som riskfaktor för malaria och 
att beskriva karaktäristika för malariapatienter i Zanzibar under 2016. 
Metod:  Detta var en retrospektiv, deskriptiv och fall-kontrollstudie som använde data från ett 
övervakningssystem för malaria i Zanzibar. Malariafallen var kliniska och bekräftades med 
snabbtest för malaria eller med mikroskopi. Övervakningssystemets databas innehöll 
information om kända riskfaktorer såsom att nyligen ha rest utanför Zanzibar, ej sovit under 
myggnät och ej gjort sprayning med insektsmedel av hemmet. 
Resultat: 48% av malariafallen på vårdcentraler uppgav att de rest utanför Zanzibar nyligen 
innan de blev sjuka. 94% av alla resor gjordes till Tanzanias fastland. Att nyligen ha rest 
utanför Zanzibar visade sig vara en stark riskfaktor för malaria med statistisk signifikans. 64% 
av alla malariafall hade använt myggnät och 31% hade gjort sprayning med insektsmedel av 
sin bostad. 
Slutsatser: Att en hög andel av alla kliniska malariafall i Zanzibar nyligen hade rest utanför 
Zanzibar antyder att en stor andel av all malaria i Zanzibar är importerad.  Användning av 
myggnät, sprayning med insektsmedel av bostad och smittspårning av malaria är faktorer som 
sannolikt påverkar spridningen av importerad malaria. Att begränsa den importerade malarian 
till Zanzibar kan vara viktigt för att åstadkomma ytterligare minskning av malaria och på sikt 
eliminera malaria i Zanzibar. 
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Appendix 
Assessment of different sources of data  
The use of different sources of data for negative controls and malaria positive in OR 
calculations for travel as risk factor for malaria at HF was assessed for fitness of use. 
As seen in Table 2.1, 16 out of 128 shehias were included in MDA surveys. The travel % of 
non-MDA shehias was 62% and MDA shehias 55%. Comparison of proportions reporting 
recent travel in MDA shehias vs non-MDA shehias showed no significant difference, 7.8% 
(CI -2-18, P=0.1). 
Table 2.1. Comparison of differences in included material from MCN data for malaria positive and survey data for malaria 
negative for period of MDA baseline survey, 30/4-15/5 in 2016 (Morris et al, unpublished). Fewer included 
shehias/municipal regions in survey data. 
South, West and Central district included. 
MCN data for all of 2016 was used in the asssessment to get enough cases. 
 
Source Periods of 
comparison 
Shehias 
included 
Range in number of 
cases per district 
Travel n/N (%; 
CI 95%) 
Range travel 
by district 
Malaria 
positive (MCN) 
Whole of 2016 Non-MDA 
shehias (N=112) 
61-387 455/730 (62% 
58.7-65.9) 
46-71% 
  
 
MDA shehias 
(N=16) 
26-57 66/121 (55%, 
45.2-63.6) 
42-63% 
  
 
All shehias 
(N=128) 
99-413 521/851 (61%, 
57.9-64.5) 
44-69% 
Malaria 
negative 
(MDA) 
MDA baseline   645-4353 36/7792 (0.99%, 
0.32-0.64) 
0.4-0.5% 
 
 
 
